Approximately 1 in 500 Australians lives with an incurable genetic neuromuscular condition that progressively deteriorates their muscle strength and function, known as muscular dystrophy. This
Novavax COVID-19 vaccine (Nuvaxovid) has been provisionally approved by the Australian Therapeutic Goods Agency (TGA) for use in adolescents aged 12 to 17 years. The
The Department of Health and Aged Care is extending its Expression of Interest (EOI) process for COVID-19 in-reach vaccination clinics until 31 December 2022, allowing
West Australian researchers have identified key differences between cancers that respond to immunotherapy and those that do not, paving the way for more effective cancer
In an Australian first, South Australia has appointed a new Assistant Minister for Autism, tasked to increase support among kids with autism in public primary schools.
A computer program may soon be able to personalise cancer treatments, improving outcomes for many sufferers. In work funded by the Cancer Council in SA, University
CSIRO scientists have led a study to develop a machine learning tool that gives medical professionals early warning of the condition of patient deterioration. The
Australia’s Biggest Quiz is set to engage communities across every State and Territory in a history-making-record-breaking event to help end Hepatitis C, and it could
Legendary sports broadcaster, Bruce McAvaney, will be fronting an event close to his heart as he prepares to host the Leukaemia Foundation’s annual Light the
NSW Health has revised the COVID-19 reinfection period from 12 weeks down to four weeks effective from today. People who have previously had COVID-19 should
The Albanese Government today launched the Cancer Hub – a national one-stop digital hub that will change the way young Australians access cancer-related services. The Cancer